Peptide neurotoxins, small-cell lung carcinoma and neurological paraneoplastic syndromes

Biochimie

Volumn 82, Issue 9-10, 2000, Pages 927-936

  Sher, Emanuele ^a   Giovannini, Federica ^b   Boot, John ^a   Lang, Betham ^b  

^a ELI LILLY AND COMPANY   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; AUTOANTIGEN; CALCIUM CHANNEL; ION CHANNEL; NEUROTOXIN; NICOTINIC RECEPTOR; OMEGA CONOTOXIN; SNAIL VENOM; SNAKE VENOM; SPIDER VENOM; VOLTAGE GATED CHANNEL FORMING PROTEIN;

ANTIBODY PRODUCTION; AUTOIMMUNITY; CROSS REACTION; DIAGNOSTIC PROCEDURE; DRUG BINDING; DRUG INHIBITION; EATON LAMBERT SYNDROME; FOLLOW UP; HORMONE RELEASE; HUMAN; ISOLATION PROCEDURE; LUNG SMALL CELL CANCER; MEMBRANE CHANNEL; NONHUMAN; PARANEOPLASTIC SYNDROME; RECEPTOR AFFINITY; REVIEW; TOXIN ANALYSIS; TUMOR GROWTH;

ARANEAE; GASTROPODA; SERPENTES; VERTEBRATA;

EID: 0033742779     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)01165-2     Document Type: Review

References (90)

1. Looking back on the discovery of alpha-bungarotoxin
2. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value
3. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and non-endocrine origin
4. Action potentials of cultured human oat cells: Whole-cell measurements with the patch-clamp technique
5. Voltage-dependent ion channels in small-cell lung cancer cells
6. Acetylcholine receptors in small cell carcinomas
7. Opiod and nicotine receptors affect growth regulation of human lung cancer cell lines
8. Neuronal-type alpha-bungarotoxin receptors and the alpha 5 nicotinic receptor subunit gene are expressed in neuronal and non-neuronal human cell lines
9. Neuronal-type nicotinic receptors in human neuroblastoma and small-cell lung carcinoma cell lines
10. Pharmacological characterisation of cholinergic receptors in a human neuroblastoma cell line
11. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms homo-oligomeric channels blocked by α-bungarotoxin
12. Serotonin release and cell proliferation are under the control of alpha-bungarotoxin-sensitive nicotinic receptors in small-cell lung carcinoma cell lines
13. Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma
14. Alpha-bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line
15. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells
16. Hippocampal synaptic transmission enhanced by low concentrations of nicotine
17. Unmasking the functions of the chromaffin cell alpha-7 nicotinic receptor by using short pulses of acetylcholine and selective blockers
18. Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma
19. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations
20. Nicotinic receptors and calcium channels in small-cell lung carcinoma: Functional role, modulation and autoimmunity
21. Alpha-conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors
22. Critical residues influence the affinity and selectivity of alpha-conotoxin MI for nicotinic acetylcholine receptors
23. Alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine blockade: Preferential inhibition of homomeric alpha 7 and alpha 9 receptors
24. Alpha-conotoxin ImI: A competitive antagonist at the alpha-bungarotoxin-sensitive neuronal nicotinic receptor in hippocampal neurons
25. Alpha-conotoxin imperialis I inhibits nicotine-evoked hormone release and cell proliferation in human neuronendocrine carcinoma cells
26. Paraneoplastic myasthenic syndrome IgG inhibits Ca flux in a human small cell carcinoma cell
27. Antagonism of voltage-gated calcium channels in small cell lung carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies, omega-conotoxin and adenosine
28. Voltage-operated calcium channels in small cell lung carcinoma cell lines: Pharmacological, functional, and immunological properties
29. ω-Conotoxin-sensitive voltage-operated calcium channels in vertebrate cells
30. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines
31. Activation of delta-opioid receptors inhibits neuronal-like calcium channels and distal steps of calcium-dependent secretion in human small-cell lung carcinoma cells
32. Splicing of alpha-1A subunite gene generates phenotypic variants of P- and Q-type calcium channels
33. Lambert-Eaton mysthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma
34. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells
35. Expression and antibody inhibition of P-type calcium channels in human small-cell lung carcinoma cells
36. Block of non-L, non-N-type calcium channels in rat insulinoma cells by w-agatoxin IVA and w-conotoxin MVIIC
37. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
38. Neuronal-type acetylcholine receptors and regulation of alpha7 gene expression in vertebrate skeletal muscle
39. Expression of the nicotinic receptor alpha7 gene in tendon and periosteum during early development
40. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leucocytes and leukimic cell lines
41. 2 on neuroendocrine cell proliferation mediated by nicotinic receptor stimulation: Significance for lung cancer risk in individuals with chronic lung disease
42. Prenatal nicotine increases pulmonary alpha 7 nicotinic receptor expression and alters fetal lung development in monkeys
43. Expression and transcriptional regulation of the human alpha3 neuronal nicotinic receptor subunit in T lymphocyte cell lines
44. Thymocytes and cultured thymic epithelial cells express transcripts encoding alpha3, alpha5 and beta4 subunits of neuronal nicotinic acetylcholine receptors: Preferential transcription of alpha3 and beta4 genes by immature CD4+8+ thymocytes
45. Human vascular endothelial cells express functional nicotinic acetylcholine receptors
46. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes
47. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors
48. Stimulation of hamster pulmonary neuroendocrine cells and associated peptides by repeated exposure to cigarette smoke
49. Simultaneous exposure to nicotine and hyperoxia causes tumors in hamsters
50. ω-Conotoxin-sensitive, voltage-operated calcium channels in insulin-secreting cells
51. Identification and cellular localisation of voltage-operated calcium channels in immature rat testis
52. Oxygen sensing in airway chemoreceptors
53. Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways
54. Aetiological factors in development of myasthenia gravis
55. Acquired neuromyotonia: Evidence for autoantibodies directed against K channels of peripheral nerves
56. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain
57. Antibodies against neuronal nicotinic receptor subtypes in neurological disorders
58. Neuronal nicotinic Ach receptor antibody in subacute autonomic neuropathy and cancer related syndromes
59. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-eaton myasthenic syndrome, a paraneoplastic disorder
60. Physiopathology of neuronal voltage-operated calcium channels
61. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome
62. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer
63. Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: A diagnostic aid for Lambert-Eaton myasthenic syndrome
64. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
65. Anti-voltage-gated calcium channel antibodies in the Lambert-eaton myasthenic syndrome
66. Specificity of autoantibodies reactive with ω-conotoxin MVIIC-sensitive calcium channels in Lambert-Eaton myasthenic syndrome
67. Immunoassay fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum
68. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome
69. Calcium channel blockers and transmitter release at the normal human neuromuscular junction
70. A novel w-conopeptide for the presynaptic localisation of calcium channels at the mammalian neuromuscular junction
71. A venom with a novel presynaptic blocking action
72. Presynaptic localisation of ω-conotoxin-sensitive calcium channels at the frog neuromuscular junction
73. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-eaton myasthenic syndrome
74. Role of autoantibodies in Lambert-Eaton myasthenic syndrome
75. Human autoantibodies specific for the α(1A) calcium chanel subunit reduce both P-type and Q-type calcium currents in cerebellar neurones
76. Differential effects of ω-conotoxin GVIA and MVIIC on nerve stimulation induced contractions of guinea-pig ileum and rat vas deferens
77. Voltage-gated calcium channels in autonomic neuroeffector transmission
78. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse
79. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-eaton myasthenic syndrome
80. The beta subunits of calcium channel complexes are Lambert-Eaton myasthenic syndrome antigens
81. Antibodies against the calcium channel beta-subunit in Lambert-eaton myasthenic syndrome
82. Antibodies against the beta subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome
83. Inhibition of low- and high-threshold calcium channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs
84. Lambert-Eaton antibodies inhibit calcium current but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells
85. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line
86. IgG from patients with the Lambert-eaton syndrome blocks voltage-dependent calcium channels
87. Lambert-Eaton sera reduce low-voltage and high-voltage activated calcium currents in murine dorsal ganglion neurons
88. Down-regulation of non-L, non-N-type (Q-like) calcium channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells
89. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system